BioSpace News Archive

Medical travelers from the United States and around the world now have the option to access a complete annual physical together with comprehensive anti-aging and wellness services in one location and over just two to three days at Bumrungrad International Hospital and its seamlessly integrated subsidiary located on the same campus downtown, VitalLife Scientific Wellness Center.

Health Canada is introducing changes to align the approach to cannabis licensing with the approach for other regulated sectors, such as pharmaceuticals.

LunaPBC, founder of LunaDNA, the first community-owned genomic and health data platform, today announced the close of $4.6 million in new funding, bringing the company’s total funding to date to $7.6 million.

FARAPULSE Inc. (“FARAPULSE” or “the “Company”) today announced it has received Breakthrough Device designation from the Center for Devices and Radiological Health (CDRH) of the U.S. Food and Drug Administration (FDA) for its Endocardial Ablation System.

TherapeuticsMD, Inc. announced that the company will participate in the Bank of America Merrill Lynch 2019 Health Care Conference.

New class of excipients offers a promising alternative to polysorbates for stabilizing proteins

Fourth-quarter fiscal 2019 revenues of $52.4 billion and full-year fiscal 2019 revenues of $214.3 billion, a full-year increase of 3%.

AstraZeneca Canada and Merck Canada today announced the Health Canada approval of Lynparza (olaparib) as a monotherapy maintenance treatment of adult patients with advanced BRCA-mutated (BRCAm) high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer who are in response (complete or partial) to first-line platinum-based chemotherapy.

Shelley Lyford, the president and CEO of nonprofit, nonpartisan West Health, has been appointed to the California Commission on Aging (CCoA) by the Senate Rules Committee, with President pro Tempore of the California State Senate Toni Atkins leading the appointment as chair of the committee.

This World Ovarian Cancer Day, Australian oncology-focused biotech company Kazia Therapeutics Ltd (ASX: KZA, NASDAQ: KZIA) calls for greater awareness of what is the most lethal gynaecological cancer in the US.